Dendritic cells pulsed with protein antigens in vitro can prime antigen-specific, MHC-restricted T cells in situ - PubMed (original) (raw)
Dendritic cells pulsed with protein antigens in vitro can prime antigen-specific, MHC-restricted T cells in situ
K Inaba et al. J Exp Med. 1990.
Erratum in
- J Exp Med 1990 Oct 1;172(4):1275
Abstract
T cells recognize peptides that are bound to MHC molecules on the surface of different types of antigen-presenting cells (APC). Antigen presentation most often is studied using T cells that have undergone priming in situ, or cell lines that have been chronically stimulated in vitro. The use of primed cells provides sufficient numbers of antigen-reactive lymphocytes for experimental study. A more complete understanding of immunogenicity, however, requires that one develop systems for studying the onset of a T cell response from unprimed lymphocytes, especially in situ. Here it is shown that mouse T cells can be reliably primed in situ using dendritic cells as APC. The dendritic cells were isolated from spleen, pulsed with protein antigens, and then administered to naive mice. Antigen-responsive T cells developed in the draining lymphoid tissue, and these T cells only recognized protein when presented on cells bearing the same MHC products as the original priming dendritic cells. In contrast, little or no priming was seen if antigen-pulsed spleen cells or peritoneal cells were injected. Since very small amounts of the foreign protein were visualized within endocytic vacuoles of antigen-pulsed dendritic cells, it is suggested that dendritic cells have a small but relevant vacuolar system for presenting antigens over a several day period in situ.
Similar articles
- Peptide-pulsed splenic dendritic cells prime long-lasting CD8(+) T cell memory in the absence of cross-priming by host APC.
Livingstone AM, Kuhn M. Livingstone AM, et al. Eur J Immunol. 2002 Jan;32(1):281-90. doi: 10.1002/1521-4141(200201)32:1<281::AID-IMMU281>3.0.CO;2-P. Eur J Immunol. 2002. PMID: 11782019 - Presentation of exogenous protein antigens by dendritic cells to T cell clones. Intact protein is presented best by immature, epidermal Langerhans cells.
Romani N, Koide S, Crowley M, Witmer-Pack M, Livingstone AM, Fathman CG, Inaba K, Steinman RM. Romani N, et al. J Exp Med. 1989 Mar 1;169(3):1169-78. doi: 10.1084/jem.169.3.1169. J Exp Med. 1989. PMID: 2522497 Free PMC article. - Dendritic cells as antigen presenting cells in vivo.
Inaba K, Metlay JP, Crowley MT, Witmer-Pack M, Steinman RM. Inaba K, et al. Int Rev Immunol. 1990;6(2-3):197-206. doi: 10.3109/08830189009056630. Int Rev Immunol. 1990. PMID: 2152503 Review. - Influences of antigen processing on the expression of the T cell repertoire. Evidence for MHC-specific hindering structures on the products of processing.
Brett SJ, Cease KB, Berzofsky JA. Brett SJ, et al. J Exp Med. 1988 Jul 1;168(1):357-73. doi: 10.1084/jem.168.1.357. J Exp Med. 1988. PMID: 2456373 Free PMC article. - Antigen presentation and T cell stimulation by dendritic cells.
Guermonprez P, Valladeau J, Zitvogel L, Théry C, Amigorena S. Guermonprez P, et al. Annu Rev Immunol. 2002;20:621-67. doi: 10.1146/annurev.immunol.20.100301.064828. Epub 2001 Oct 4. Annu Rev Immunol. 2002. PMID: 11861614 Review.
Cited by
- Dendritic cell vaccination combined with irreversible electroporation for treating pancreatic cancer-a narrative review.
Zhang Z, Yu G, Eresen A, Chen Z, Yu Z, Yaghmai V, Zhang Z. Zhang Z, et al. Ann Transl Med. 2024 Aug 1;12(4):77. doi: 10.21037/atm-23-1882. Epub 2024 May 28. Ann Transl Med. 2024. PMID: 39118942 Free PMC article. Review. - Enhanced antigen-specific CD8 T cells contribute to early protection against FMDV through swine DC vaccination.
Mu S, Chen L, Dong H, Li S, Zhang Y, Yin S, Tian Y, Ding Y, Sun S, Shang S, Guo H. Mu S, et al. J Virol. 2024 Feb 20;98(2):e0200223. doi: 10.1128/jvi.02002-23. Epub 2024 Jan 30. J Virol. 2024. PMID: 38289108 Free PMC article. - Optimizing the generation of mature bone marrow-derived dendritic cells in vitro: a factorial study design.
Alotaibi N, Aldahlawi A, Zaher K, Basingab F, Alrahimi J. Alotaibi N, et al. J Genet Eng Biotechnol. 2023 Nov 29;21(1):144. doi: 10.1186/s43141-023-00597-4. J Genet Eng Biotechnol. 2023. PMID: 38017248 Free PMC article. - Advances and key focus areas in gastric cancer immunotherapy: A comprehensive scientometric and clinical trial review (1999-2023).
Li YN, Xie B, Zhang Y, He MH, Xing Y, Mu DM, Wang H, Guo R. Li YN, et al. World J Gastroenterol. 2023 Oct 28;29(40):5593-5617. doi: 10.3748/wjg.v29.i40.5593. World J Gastroenterol. 2023. PMID: 37970478 Free PMC article. Review. - Characterization of CAR T Cells Manufactured Using Genetically Engineered Artificial Antigen Presenting Cells.
Sayadmanesh A, Azadbakht M, Yari K, Abedelahi A, Shafaei H, Shanehbandi D, Baradaran B, Basiri M. Sayadmanesh A, et al. Cell J. 2023 Oct 9;25(10):674-687. doi: 10.22074/cellj.2023.2001712.1304. Cell J. 2023. PMID: 37865876 Free PMC article.
References
- J Exp Med. 1978 Apr 1;147(4):1142-58 - PubMed
- J Exp Med. 1976 May 1;143(5):1283-8 - PubMed
- Proc Natl Acad Sci U S A. 1978 Oct;75(10):5132-6 - PubMed
- J Exp Med. 1979 Aug 1;150(2):218-30 - PubMed
- J Immunol. 1980 Mar;124(3):1258-62 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials